Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Jan 31, 2026 | (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -51.44%-484.96K | 9.74%-454.59K | -46.25%-575.26K | -526.71%-1.61M | -141.74%-395.58K | 65.20%-320.22K | -288.81%-503.63K | -153.13%-393.34K | 35.22%-257.34K | 1,633.00%947.73K |
| Net income from continuing operations | 153.29%542.72K | 133.76%538.45K | 56.20%-789.81K | -1,650.68%-4.97M | -38.32%-551.56K | -143.65%-1.02M | -339.65%-1.6M | -44.14%-1.8M | 105.51%320.41K | 79.92%-398.75K |
| Operating gains losses | -104.18%-19.25K | 93.16%-31.83K | 124.01%18.59K | 83.76%-79.05K | -97.48%2.53K | 679.72%461.03K | -0.31%-465.16K | -77.23%-77.44K | -144.34%-486.69K | -30.06%100.28K |
| Depreciation and amortization | -10.58%4.17K | -3.53%4.64K | -23.39%3.69K | -24.77%18.94K | -31.12%4.66K | -20.01%4.66K | -16.96%4.81K | -29.18%4.81K | -43.71%25.18K | 64.25%6.76K |
| Asset impairment expenditure | ---- | ---- | ---- | -98.43%7.5K | -97.17%7.5K | ---- | ---- | ---- | -24.42%476.91K | -57.94%265.41K |
| Unrealized gains and losses of investment securities | -1,506.38%-1.18M | -182.75%-1.1M | -74.59%384.4K | 297.96%2.78M | 103.40%5.94K | 97.68%-73.76K | 74.76%1.34M | 27.43%1.51M | -132.11%-1.4M | -116.48%-174.69K |
| Remuneration paid in stock | -32.88%144.44K | -2.02%56.72K | -69.39%17.72K | -44.79%348.1K | -77.30%17.14K | -61.23%215.18K | --57.89K | --57.89K | --630.52K | --75.52K |
| Change In working capital | -69.40%27.88K | -48.12%82.34K | -138.72%-209.86K | 55.02%280.13K | -35.94%118.21K | 192.10%91.12K | 9.36%158.71K | -75.72%-87.91K | -67.76%180.71K | -11.69%184.53K |
| -Change in receivables | -93.94%3.28K | 126.03%19.66K | -77.97%1.71K | -109.05%-6.84K | -94.20%6.81K | 151.34%54.09K | -198.57%-75.52K | 160.03%7.78K | -66.12%75.57K | -52.36%117.26K |
| -Change in prepaid assets | -7.73%-12.05K | -300.16%-29.54K | -3,157.74%-47.4K | 119.11%7.19K | -90.36%2.07K | -370.53%-11.19K | -53.92%14.76K | 101.63%1.55K | -106.74%-37.6K | -11.50%21.46K |
| -Change in payables and accrued expense | -23.98%36.66K | -57.98%92.22K | -68.84%-164.17K | 96.01%279.78K | 138.62%109.33K | 2,017.52%48.22K | 501.45%219.48K | -267.21%-97.24K | 164.81%142.74K | 174.57%45.82K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -51.16%-484.96K | 9.74%-454.59K | -46.25%-575.26K | -526.71%-1.61M | -141.68%-394.99K | 65.13%-320.82K | -288.81%-503.63K | -153.13%-393.34K | 35.22%-257.34K | 1,633.00%947.73K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 140.95%811.82K | 13.35%639.27K | 0.98%376.55K | 324.90%1.75M | 150.98%474.08K | 852.39%336.92K | 456.69%563.98K | 2,226.89%372.88K | -657.00%-777.16K | -148.86%-929.87K |
| Net PPE purchase and sale | --243.77K | ---243.33K | -119.40%-24.72K | 112.25%127.41K | --0 | --0 | --0 | 497.52%127.41K | -913.24%-1.04M | -186.01%-1.07M |
| Net investment purchase and sale | 68.60%568.05K | 56.49%882.6K | 63.47%401.27K | 515.99%1.62M | 241.53%474.08K | 342.27%336.92K | --563.98K | 410.61%245.48K | --263.06K | --138.81K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 140.95%811.82K | 13.35%639.27K | 0.98%376.55K | 324.90%1.75M | 150.98%474.08K | 852.39%336.92K | 456.69%563.98K | 2,226.89%372.88K | -657.00%-777.16K | -148.86%-929.87K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 992.99K | -467.01K | ||||||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---40K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --1.48M | ---25K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---442.01K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --992.99K | ---467.01K |
| Net cash flow | ||||||||||
| Beginning cash position | 38.26%293.33K | -28.43%108.65K | 78.42%307.36K | -19.41%172.27K | -63.17%228.86K | 359.37%212.17K | 104.03%151.81K | -19.41%172.27K | -70.05%213.77K | 16.65%621.42K |
| Current changes in cash | 1,857.70%326.86K | 206.00%184.68K | -871.39%-198.71K | 425.49%135.09K | 117.48%78.49K | -97.10%16.7K | 313.86%60.35K | 85.32%-20.46K | 91.70%-41.5K | -40.81%-449.15K |
| End cash Position | 170.99%620.19K | 38.26%293.33K | -28.43%108.65K | 78.42%307.36K | 78.42%307.36K | -63.17%228.86K | 359.37%212.17K | 104.03%151.81K | -19.41%172.27K | -19.41%172.27K |
| Free cash from | -192.39%-938.02K | -38.58%-697.91K | -52.53%-599.98K | -13.25%-1.61M | -218.82%-394.99K | 66.61%-320.82K | -231.91%-503.63K | -109.85%-393.34K | -216.50%-1.42M | -378.80%-123.89K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.